Enzyme immunoassay detection of Cryptosporidium parvum inhibition by sinefungin in sporozoite infected HCT-8 enterocytic cells

被引:18
作者
Gargala, G [1 ]
Delaunay, A
Favennec, L
Brasseur, P
Ballet, JJ
机构
[1] CHU Caen, UPRESEA 2128, Lab Immunol & Immunopathol, F-14033 Caen, France
[2] CHU, UPRESJE 2008, Lab Parasitol Expt, F-76000 Rouen, France
关键词
Cryptosporidium parvum; HCT-8; cells; enzyme immunoassay; sinefungin; paromomycin; pentamidine dimethanesulfonate;
D O I
10.1016/S0020-7519(99)00031-4
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Complete parasite development was obtained in differentiated human enterocytic HCT-8 cells infected at confluence with Cryptosporidium parvum sporozoites, and evaluated in a quantitative enzyme imunoassay. Forty-eight hours after infection, a linear correlation was found between optical density values and the number of parasites determined in an immunofluorescent assay. Sinefungin exerted an inhibitory effect when added within 4 h after sporozoite addition to HCT-8 cultures (MIC50 = 38 mu mol L-1). while the inhibitory effects of paromomycin and pentamidine dimethanesulfonate were also easily detected (MIC50 = 0.87 mu mol L-1 and 0.27 mu mol L-1, respectively). Except for high pentamidine dimethanesulfonate concentrations, no alteration in optical microscopy morphology or trypan blue exclusion of HCT-8 cells was observed in the presence of anticryptosporidial agents, which suggests that they were primarily active against developing parasites. Data suggest that EIA detection of C. parvum development in sporozoite-infected HCT-8 cells provides an accurate and convenient model for in vitro evaluation of parasite infectivity, growth and response to anticryptosporidial agents. (C) 1999 Australian Society for Parasitology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 19 条
[1]  
BLAGBURN BL, 1997, CRYPTOSPORIDIUM CRYP, P111
[2]  
BRASSEUR P, 1991, J PROTOZOOL, V38, pS230
[3]   ALKALINE-PHOSPHATASE FOR IMMUNO-CYTOCHEMICAL LABELING - PROBLEMS WITH ENDOGENOUS ENZYME-ACTIVITY [J].
BULMAN, AS ;
HEYDERMAN, E .
JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (12) :1349-1351
[4]   Inhibition of complete development of Cryptosporidium parvum in caco-2 cells [J].
EgrazBernard, M ;
Favennec, L ;
Agnamey, P ;
Ballet, JJ ;
Brasseur, P .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (11) :897-900
[5]   ATTACHMENT OF CRYPTOSPORIDIUM-PARVUM SPOROZOITES TO MDCK CELLS IN-VITRO [J].
HAMER, DH ;
WARD, H ;
TZIPORI, S ;
PEREIRA, MEA ;
ALROY, JP ;
KEUSCH, GT .
INFECTION AND IMMUNITY, 1994, 62 (06) :2208-2213
[6]   ASSESSMENT OF CANDIDATE ANTICRYPTOSPORIDIAL AGENTS IN AN IMMUNOSUPPRESSED RAT MODEL [J].
LEMETEIL, D ;
ROUSSEL, F ;
FAVENNEC, L ;
BALLET, JJ ;
BRASSEUR, P .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) :766-768
[7]  
Maillot C, 1997, J EUKARYOT MICROBIOL, V44, P582, DOI 10.1111/j.1550-7408.1997.tb05963.x
[8]   PAROMOMYCIN INHIBITS CRYPTOSPORIDIUM INFECTION OF A HUMAN ENTEROCYTE CELL-LINE [J].
MARSHALL, RJ ;
FLANIGAN, TP .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :772-774
[9]  
MESSIKA E, 1990, TROP MED PARASITOL, V41, P273
[10]   Cryptosporidiosis: Laboratory investigations and chemotherapy [J].
Tzipori, S .
ADVANCES IN PARASITOLOGY - OPPORTUNISTIC PROTOZOA IN HUMANS, 1998, 40 :187-221